Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma by Xin Wang, Pei Zhang, Jie Tian, Jie Wang, Zhijie Wang, Hua Bai, Jianchun Duan, Di Wang, Jiefei Han, Yanhua Tian, Xiran He, Yang Du, Rui Wan, Jiachen Xu, Kailun Fei

Get full text

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma by Xin Wang, Li Zhang, Jie Wang, Jing Sun, Yu Xu, Zhijie Wang, Hua Bai, Jianchun Duan, Wenfeng Fang, Guoqiang Wang, Rui Wan, Jiachen Xu, Kailun Fei, Chengcheng Li, Wenzhuan Xie, Zhengyi Zhao, Shangli Cai

Get full text

Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3... by Jia Zhong, Kailun Fei, Lin Wu, Baolan Li, Zhijie Wang, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qiming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, An-Wen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Liyun Miao, Zhihong Zhang, Hui Zhao, Jun Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Shi Jin, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Sheng Yao, Jianjun Yu, Shang li Cai, Yiran Cai, Jiachen Xu, Wei Zhuang, Xianmin Luo, Jianchun Duan, Jie Wang

Get full text